Figure 1G demonstrated that UBE2C expression was significantly increased in HCC, identical with the analytic results from Oncomine database. Expression difference of UBE2C among various stages of HCC was also assessed using TCGA HCC data. A significant expression difference of UBE2C was observed among 4 different HCC stages as shown in Figure 1H, with F-value = 8.6 and P-value = 1.62e-05. Notably, Figure 1H revealed that UBE2C expression increased with the rise of cancer stage. This evidence concerns the gene UBE2C and hepatocellular carcinoma.